Form 4 for OBIO Orchestra BioMed Holdings, Inc.

Accepted 2023-07-24 00:00:00 ET · period of report 2023-07-20 · accession 0001104659-23-083497 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-07-24	2023-07-20	OBIO	Aiello Joshua	Principal Accounting Off	A - Grant	$0.00	+5,000	5,000	New	$0
D	2023-07-24	2023-07-20	OBIO	Aiello Joshua	Principal Accounting Off	A - Grant	$0.00	+7,500	7,500	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.0001 per share ("Common Stock")	2023-07-20	A	A	5,000	$0.00	5,000	D	—	—	(F1) Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of the grant date, (ii) 33% the shares will vest on the two-year anniversary of the grant date, and (iii) 33% the shares will vest on the three-year anniversary of the grant date, subject to the Reporting Person's continuous service through such dates.
2	Derivative	Stock Option (Right to Buy)	2023-07-20	A	A	7,500	$0.00	7,500	D	$7.42 · — to 2033-07-20	7,500 Common Stock	(F2) The stock options vest over a four-year period as follows: (i) 25% of the underlying shares will vest on the one-year anniversary of the grant date and (ii) 75% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting on the last day of the first quarter after the first anniversary of the grant date, or September 30, 2024, subject to the Reporting Person's continuous service through such dates.